medigraphic.com
ISSN 2007-3194 (Print)
Órgano de difusión oficial del Instituto Materno Infantil del Estado de México

2016, Number 2

<< Back Next >>

Arch Inv Mat Inf 2016; 8 (2)

Lipid profile in normotensive full-term pregnancy patients and those with preeclampsia

Arellano SV, Garay SG

Language: Spanish
References: 18
Page: 55-61
PDF size: 110.78 Kb.


ABSTRACT

Introduction: Preeclampsia is a condition that generates maternal morbidity and mortality; its incidence in Mexico is 8% and it represents 34% of maternal deaths. Currently, there is little information in the literature regarding the lipid profile of pregnant patients and the relationship of hypercholesterolemia and hypertriglyceridemia with the hypertensive states of pregnancy. There are studies in which the link between dyslipidemia and the hypertensive disorders of pregnancy is observed. Objective: To determine the OR (odds ratio) and confidence intervals in the lipid profile of normotensive full-term pregnancy patients compared with those with preeclampsia treated at the Hospital of Gynecology and Obstetrics, Maternal and Child Institute of the State of Mexico, from January to June 2014. Material and methods: A cross-sectional study was performed in which the records of 160 full-term pregnancy patients who met the selection criteria were analyzed. They were divided into 2 groups: 1) consisted of 80 normotensive women and 2) comprised 80 patients with preeclampsia, of which 49 had mild preeclampsia and 31 severe preeclampsia. Their levels of cholesterol and triglycerides were taken during the third trimester of pregnancy. Results: The results of this research show that patients with preeclampsia have triglyceride (337.19 ± 109 mg/dL) and cholesterol (264.8 ± 100.9) levels higher than those of normotensive pregnant women (triglycerides 271.20 ± 108.3 mg/dL, cholesterol 225 ± 48.96 mg/dL). Conclusions: The levels of cholesterol and triglycerides are higher in patients who develop preeclampsia compared with those of normotensive patients.


REFERENCES

  1. Hernández-Pacheco JA, Espino-y Sosa S, Estrada-Altamirano A, Nares-Torices MA, de J Ortega Casitillo VM, Mendoza-Calderón SA et al, Instrumentos de la Guía de Práctica Clínica. Diagnóstico y tratamiento de la preeclampsia y eclampsia en el embarazo, parto y puerperio, Perinatil Reprod Hum, 2013; 27 (4): 262-280.

  2. CENETEC, Detección y diagnóstico de enfermedades hipertensivas del embarazo, GPC, evidencias y recomendaciones, México: Instituto Mexicano del Seguro Social, CENETEC; 2010.

  3. Hernández-Pacheco JA, Espino-y-Sosa S, Figueroa-Damián R, Preeclampsia-eclampsia, hemorragia postparto y sepsis obstétrica, México: Editorial Intersistemas; 2014. 3-45.

  4. Federación Mexicana de Ginecología y Obstetricia, PAC GO-3, Programa de Actualización Continua en Ginecología y Obstetricia, Hipertensión arterial y embarazo, México: Editorial Intersistemas; 2013. 693-731.

  5. Sánchez-Rodríguez EN, Nava-Salazar S, Morán C, Romero-Arauz JF, Cerbón-Cervantes MA, Estado actual de la preeclampsia en México: de lo epidemiológico a sus mecanismos moleculares, Rev Inv Clin, 2010; 62 (3): 252-260.

  6. Spracklen CN, Smith CJ, Saftls AF, Robinson JG, Ryckman KK, Maternal hyperlipidemia and the risk of preeclampsia: a meta-analysis, Am J Epidemiol, 2014; 180 (4): 346-358.

  7. American College of Obstetricians and Gynecologists, Hypertension in pregnancy. Report of the American College of Obstetricians and Ginecologists’ task force on hypertension in pregnancy, Obstet Gynecol, 2013; 122 (5): 1122-1131.

  8. Herrera-Villalobos JE, Garay SG, Adaya LE, Camacho BR, Garduño AA, Nava DP, Riesgo de dislipidemia en pacientes que han sufrido preeclampsia, Arch Inv Mat Inf, 2010; 2 (2): 67-70.

  9. Gómez O, Figueras F, Bellart J, Plaza A, Guía Clínica, hipertensión inducida por la gestación: hipertensión gestacional y preeclampsia, Barcelona: Instituto Clínico de Ginecología, Obstetricia y Neonatología; 2008.

  10. American College of Obstetricians and Gynecologists, ACOG Practice Bulletin No. 125: Chronic hypertension in pregnancy, Obstet Gynecol, 2012; 119 (2 Pt 1): 396-407.

  11. Villanueva EL, Collado PS, Conceptos actuales sobre la preeclampsia-eclampsia, Rev Fac Med UNAM, 2007; 50 (2): 57-61.

  12. Aragón-Charris J, Reyna-Villasmil E, Guerra-Velásquez M, Mejía-Montilla J, Torres-Cepeda D, Santos-Bolívar J et al, Índice aterogénico del plasma en pacientes con preeclampsia y embarazadas sanas, Med Clin, 2014; 143: 104-108.

  13. Gallos ID, Sivakumar K, Kilby MD, Coomarasamy A, Thangaratinam S, Vatish M, Pre-eclampsia is associated with, and preceded by, hypertriglyceridemia: a meta-analysis, BJOG, 2013; 120 (11): 1321-1332.

  14. NICE, Clinical guideline, hypertension in pregnancy: the management of hypertensive disorders during pregnancy. 2011.

  15. Sibai BM, Diagnosis, prevention and management of eclampsia, Obstet Gynecol, 2005; 105 (2): 402-410.

  16. Spracklen CN, Saftlas AF, Triche EW, Bjonnes A, Keating B, Saxena R et al, Genetic predisposition to dyslipidemia and risk of preeclampsia, Am J Hypertens, 2014; 28 (7): 915-923.

  17. Stiefel P, Miranda M, Bellido L, Luna J, Jiménez L, Pamies E et al, Genotype of the CYBA promoter -930A/G, polymorphism C677T of the MTHFE and APOE genotype in patients with hypertensive disorders of pregnancy: an observational study, Med Clin (Barc), 2009; 133: 657-661.

  18. Duarte-Mote J, Pérez-Torres C, Espinosa-López R, Eng-Castro VL, Calvo-Colindres J, Sánchez-Rojas G et al, Relación entre dislipidemia y severidad en preeclampsia, Rev Med Inst Mex Seguro Soc, 2014; 52 (5): 516-520.




2020     |     www.medigraphic.com